ID
13945
Description
A randomised comparison of daily 25 mg versus 5 mg lenalidomide as maintenance therapy after high-dose therapy and autologous stem cell transplantation in patients with multiple myeloma. Protocol-Code: RV-MM-PI-280 EudraCT-Number: 2007-003945-33 Author: Claus Schreiber Review: Gerd Felder Approval of CRF: Prof. Dr. med. G. Kobbe (LKP) Release for MDM: Prof. Gattermann, Düsseldorf (26.1.2016) Principal Investigator „LenaMain“-Studie: Prof. Roland Fenk, Düsseldorf Coordinating center for clinical trial Medical faculty of University Hospital Heinrich-Heine-University Scientific Director: Herr Dr. J. Grebe Moorenstrasse 5 40225 Düsseldorf Tel.: +49 (0) 211-81-19701 Fax: +49 (0) 211-81-19702
Keywords
Versions (1)
- 3/17/16 3/17/16 -
Uploaded on
March 17, 2016
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Fourth Follow-up LenaMain-Study
Fourth Follow-Up
- StudyEvent: ODM
Description
Survival Status
Description
Survival Status
Data type
integer
Alias
- UMLS CUI [1]
- C1148433
Description
Date of death
Data type
date
Alias
- UMLS CUI [1]
- C1148348
Description
Death certificate
Data type
boolean
Alias
- UMLS CUI [1]
- C0011066
Description
Autopsy
Data type
boolean
Alias
- UMLS CUI [1]
- C0004398
Description
Cause of death
Data type
integer
Alias
- UMLS CUI [1]
- C0007465
Description
Cause of death
Data type
text
Alias
- UMLS CUI [1]
- C0007465
Similar models
Fourth Follow-Up
- StudyEvent: ODM
C0040808 (UMLS CUI [1,2])